These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 2537716)

  • 21. Vipoma, glucagonoma and the role of Sandostatin.
    Bloom SR
    NATNEWS; 1989 Jul; 26(7):15. PubMed ID: 2550822
    [No Abstract]   [Full Text] [Related]  

  • 22. Clinical evaluation of SMS 201-995. Long-term treatment in gut neuroendocrine tumours, efficacy of oral administration, and possible use in non-tumoural inappropriate TSH hypersecretion.
    Williams G; Anderson JV; Williams SJ; Bloom SR
    Acta Endocrinol Suppl (Copenh); 1987; 286():26-36. PubMed ID: 2892335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Malignant insulinoma: lack of response to the somatostatin analog SMS 201-955].
    Ligorria C; Montaña E; Virgili N
    Med Clin (Barc); 1989 Nov; 93(17):676. PubMed ID: 2559266
    [No Abstract]   [Full Text] [Related]  

  • 24. The somatostatin analogue SMS 201-995 in long-term treatment of vipoma. Case report.
    Christensen C
    Acta Chir Scand; 1989 Oct; 155(10):541-3. PubMed ID: 2557717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of inoperable glucagonoma with the long-acting somatostatin analogue SMS 201-995.
    Boden G; Ryan IG; Eisenschmid BL; Shelmet JJ; Owen OE
    N Engl J Med; 1986 Jun; 314(26):1686-9. PubMed ID: 2872592
    [No Abstract]   [Full Text] [Related]  

  • 26. The use of SMS 201-995 (somatostatin analogue) in insulinomas. Additional case report and literature review.
    Hearn PR; Ahmed M; Woodhouse NJ
    Horm Res; 1988; 29(5-6):211-3. PubMed ID: 2851522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic treatment of a benign insulinoma using the long-acting somatostatin analogue SMS 201-995.
    Glaser B; Rösler A; Halperin Y
    Isr J Med Sci; 1990 Jan; 26(1):16-9. PubMed ID: 2155884
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression of metastatic vipoma with somatostatin analogue SMS 201-995.
    Clements D; Elias E
    Lancet; 1985 Apr; 1(8433):874-5. PubMed ID: 2858733
    [No Abstract]   [Full Text] [Related]  

  • 29. Pseudopancreatic cholera syndrome: effect of a synthetic somatostatin analogue, SMS 201-995.
    Santangelo WC; Dueno MI; Krejs GJ
    Am J Med; 1987 May; 82(5B):84-7. PubMed ID: 2884881
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of octreotide in the treatment of digestive endocrine tumors. A French multicenter study].
    Blanchin M; James-Deidier A; Chaumet-Riffaud PD; Chayvialle JA
    Presse Med; 1992 Apr; 21(15):697-702. PubMed ID: 1376476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Octreotide--a synthetic somatostatin.
    Med Lett Drugs Ther; 1989 Jul; 31(796):66-8. PubMed ID: 2567960
    [No Abstract]   [Full Text] [Related]  

  • 32. Use of a somatostatin analog (SMS 201-995) in the glucagonoma syndrome.
    Altimari AF; Bhoopalam N; O'Dorsio T; Lange CL; Sandberg L; Prinz RA
    Surgery; 1986 Dec; 100(6):989-96. PubMed ID: 2878500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A somatostatin analogue inhibits chondrosarcoma and insulinoma tumour growth.
    Reubi JC
    Acta Endocrinol (Copenh); 1985 May; 109(1):108-14. PubMed ID: 2860768
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of insulinoma with the somatostatin analog SMS 201-995].
    Gilsanz Peral A; Gómez Balaguer M; Costa Talens P
    Med Clin (Barc); 1988 Apr; 90(15):634-5. PubMed ID: 2899658
    [No Abstract]   [Full Text] [Related]  

  • 35. Long-acting somatostatin analogues in pancreatic islet cell carcinoma.
    Souquet JC
    Horm Res; 1989; 32(1-3):74-6. PubMed ID: 2559020
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The somatostatin analog SMS 201-995 in long-term treatment of vipoma].
    Christensen C
    Ugeskr Laeger; 1990 Dec; 152(51):3851-3. PubMed ID: 2177234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A case of somatostatinoma: responses to food and SMS 201-995 administration.
    Davis TM; Bray G; Domin J; Bloom SR
    Pancreas; 1988; 3(6):729-33. PubMed ID: 2906126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Non-pituitary actions of somatostatin. A review on the therapeutic role of SMS 201-995 (sandostatin).
    Lamberts SW
    Acta Endocrinol Suppl (Copenh); 1986; 276():41-55. PubMed ID: 2875590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical review 23: The use of the long-acting somatostatin analog octreotide in the treatment of gut neuroendocrine tumors.
    Wynick D; Bloom SR
    J Clin Endocrinol Metab; 1991 Jul; 73(1):1-3. PubMed ID: 1646213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Successful treatment of a VIPoma by continuous subcutaneous infusion of somatostatin analogue (SMS 201-995).
    Niitsu Y; Goto Y; Maeda M; Tsushima N; Watanabe N; Kohgo Y; Urushizaki I
    Aliment Pharmacol Ther; 1988 Jun; 2(3):269-79. PubMed ID: 2856504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.